DK1059921T3 - Anvendelse af macrolidforbindelser til behandling af ARDS - Google Patents

Anvendelse af macrolidforbindelser til behandling af ARDS

Info

Publication number
DK1059921T3
DK1059921T3 DK99937870T DK99937870T DK1059921T3 DK 1059921 T3 DK1059921 T3 DK 1059921T3 DK 99937870 T DK99937870 T DK 99937870T DK 99937870 T DK99937870 T DK 99937870T DK 1059921 T3 DK1059921 T3 DK 1059921T3
Authority
DK
Denmark
Prior art keywords
treatment
ards
macrolide compounds
compounds
macrolide
Prior art date
Application number
DK99937870T
Other languages
English (en)
Inventor
Tadatsura Koshika
Itsuo Nagatomi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK1059921T3 publication Critical patent/DK1059921T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Steroid Compounds (AREA)
DK99937870T 1998-03-06 1999-03-04 Anvendelse af macrolidforbindelser til behandling af ARDS DK1059921T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2231A AUPP223198A0 (en) 1998-03-06 1998-03-06 New use
PCT/JP1999/001064 WO1999044597A2 (en) 1998-03-06 1999-03-04 Use of macrolide compounds for the treatment of ards

Publications (1)

Publication Number Publication Date
DK1059921T3 true DK1059921T3 (da) 2003-10-27

Family

ID=3806495

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99937870T DK1059921T3 (da) 1998-03-06 1999-03-04 Anvendelse af macrolidforbindelser til behandling af ARDS

Country Status (14)

Country Link
US (1) US6333334B1 (da)
EP (1) EP1059921B1 (da)
JP (1) JP3367105B2 (da)
KR (1) KR100395571B1 (da)
CN (1) CN1133429C (da)
AT (1) ATE244008T1 (da)
AU (1) AUPP223198A0 (da)
BR (1) BR9908796A (da)
CA (1) CA2322027C (da)
DE (1) DE69909257T2 (da)
DK (1) DK1059921T3 (da)
ES (1) ES2196840T3 (da)
PT (1) PT1059921E (da)
WO (1) WO1999044597A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
EP2071917B1 (en) * 2006-09-29 2012-11-21 Infa S.A. Packaging system for pharmaceutical compositions and kit for intravenous administration
MX2009006958A (es) * 2006-12-28 2009-07-09 Limerick Biopharma Inc Metodos y composiciones para tratamiento terapeutico.
JP2010515753A (ja) 2007-01-10 2010-05-13 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 肺内送達用免疫抑制剤組成物の送達の増強
CN101011414B (zh) * 2007-01-29 2010-07-21 褚福明 一种肺脑合剂药物
EP2182957A4 (en) * 2007-07-31 2012-07-18 Limerick Biopharma Inc PHOSPHORYLATED PYRONANALOGES AND CORRESPONDING METHODS
CN101810633B (zh) * 2010-03-31 2011-12-14 湖北丝宝药业有限公司 地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途
GB201212773D0 (en) * 2012-07-18 2012-08-29 Ucl Business Plc Vascular remodelling
CN117015375A (zh) * 2020-05-28 2023-11-07 福尔医学公司 用于治疗由冠状病毒引起的急性呼吸窘迫综合征(ards)和炎性病症的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
WO1992008474A2 (en) * 1990-11-20 1992-05-29 The National Heart & Lung Institute Treatment of lung diseases
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5290689A (en) * 1992-09-28 1994-03-01 Merck & Co., Inc. New cyclic FR-900520 microbial biotransformation agent

Also Published As

Publication number Publication date
WO1999044597A3 (en) 1999-12-29
AUPP223198A0 (en) 1998-04-02
ES2196840T3 (es) 2003-12-16
PT1059921E (pt) 2003-11-28
US6333334B1 (en) 2001-12-25
WO1999044597A2 (en) 1999-09-10
CA2322027A1 (en) 1999-09-10
HK1036406A1 (en) 2002-01-04
DE69909257D1 (de) 2003-08-07
KR20010041046A (ko) 2001-05-15
ATE244008T1 (de) 2003-07-15
JP2001520682A (ja) 2001-10-30
JP3367105B2 (ja) 2003-01-14
BR9908796A (pt) 2000-10-31
EP1059921A2 (en) 2000-12-20
KR100395571B1 (ko) 2003-08-21
CN1133429C (zh) 2004-01-07
CN1292695A (zh) 2001-04-25
EP1059921B1 (en) 2003-07-02
CA2322027C (en) 2009-05-12
DE69909257T2 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
TR200101412T2 (tr) Yeni bileşikler.
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
DK0842934T3 (da) 5-HT1F agonister
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
ES2243579T3 (es) Derivados de pirazolopirideno.
NO20005793D0 (no) Sammensetninger som inneholder organisk mono- eller dinitrat for behandling av impotens
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
SE9604348D0 (sv) Användning av hydroxyguanidiner
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
BR9908796A (pt) Uso de compostos de macrolìdeo, método de tratamento e prevenção de ards, composição farmacêutica e composto macrolìdeo
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
DE60116106D1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
PY990129A (es) Bromhidrato de eletriptan monohidratado
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
DK1607090T3 (da) Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier